Taichung, Taiwan

Li-Chuan Hsu

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Li-Chuan Hsu in Biotechnology

Introduction

Li-Chuan Hsu is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of cancer treatment. His innovative work has led to the development of a unique process for preparing a specific extract that holds promise for pharmaceutical applications.

Latest Patents

Li-Chuan Hsu holds a patent titled "Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract." This invention provides a method for preparing an extract and outlines its potential use in the prevention or treatment of cancer. The patent emphasizes the pharmaceutical composition that includes this extract, showcasing its relevance in medical science.

Career Highlights

Hsu is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in the field. His work has not only contributed to scientific knowledge but also has practical implications for cancer therapy.

Collaborations

Li-Chuan Hsu has collaborated with notable colleagues, including Tsui Hsu Chan and Yuh Shan Chung, who have supported his research endeavors. Their combined expertise has enhanced the impact of their work in biotechnology.

Conclusion

Li-Chuan Hsu's innovative contributions to biotechnology, particularly in cancer treatment, highlight the importance of research and development in improving healthcare solutions. His patent and collaborative efforts reflect a commitment to advancing medical science for the benefit of society.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…